NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Changes in Eosinophil Cationic Protein and Sputum Eosinophils Following Allergen Immunotherapy

CompletedNA

Sponsor: Mansoura University Hospital

Conditions: Allergic Asthma

Interventions: Allergen Immunotherapy Extract

Countries: Egypt

Asthma is a chronic heterogeneous inflammatory airway disease affecting millions worldwide and remains a major global health burden. Despite advances in pharmacological therapy, a substantial proportion of patients continue to experience uncontrolled symptoms due to persistent airway inflammation and disease heterogeneity.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Age above 18 years and diagnosed of allergic asthma. Patients were clinical stabile and confirmed diagnosis supported by pulmonary function test.

Exclusion Criteria:

* pregnant
* parasitic infestations
* recent acute asthma exacerbation
* current smoking
* severe persistent asthma

Locations (1)

Al Mansurah, Egypt